The Catholic University of Korea, Bucheon St. Mary's Hospital
Bucheon-si, 14647, South Korea
Location status: Recruiting
NCT Number: NCT06305949
The goal of this clinical trial is to evaluate whether the application of optimized transcranial direct current stimulation is more effective compared to sham stimulation for temporary improvement of swallowing function in patients with post-stroke dysphagia.
Interested in participating?
Request Info19 year and older
All sexes
Interventional
Not applicable
Bucheon-si, 14647, South Korea
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
transcranial Direct Current Stimulation 2mA for 30 min; The anode electrode will be located over the contralesional representation of the motor cortex swallowing area, while the cathode electrode will be positioned on the ipsilesional side
Other names: NEUROPHET tES LAB, NEUROPHET innk01-DW
transcranial Direct Current sham Stimulation for 30 min; The anode electrode will be located over the contralesional representation of the motor cortex swallowing area, while the cathode electrode will be positioned on the ipsilesional side
Other names: NEUROPHET tES LAB, NEUROPHET innk01-DW
Time frame: Baseline, At 4 weeks from baseline
FOIS is a scale used for purposes to assess changes in functional oral intake of food and liquids in patients with dysphagia. FOIS is sensitive to changes in oral intake of food and liquid over time in stroke patients. The scale ranges from level 1 (nothing by mouth) to level 7 (a full unrestricted oral diet)
Time frame: Baseline, At 4 weeks from baseline
PAS is a standard scale to assess deglutition in clinical practice and research. It is composed of an 8-point scale used to characterize both the location of airway invasion events and patient's response during video fluoroscopic swallowing studies. The scale design to capture three constructs: depth of airway invasion, material remaining after swallow, and patient's response to aspiration. The scale ranges from score 1 (Material does not enter the airway) to score 8 (Material enters the airway, passes below the level of the vocal folds, and no effort is made to eject)
Time frame: Baseline, At 2, 4, and 8 weeks from baseline
FOIS is a scale used for purposes to assess changes in functional oral intake of food and liquids in patients with dysphagia. FOIS is sensitive to changes in oral intake of food and liquid over time in stroke patients. The scale ranges from level 1 (nothing by mouth) to level 7 (a full unrestricted oral diet)
Time frame: Baseline, At 2, 4, and 8 weeks from baseline
PAS is a standard scale to assess deglutition in clinical practice and research. It is composed of an 8-point scale used to characterize both the location of airway invasion events and patient's response during video fluoroscopic swallowing studies. The scale design to capture three constructs: depth of airway invasion, material remaining after swallow, and patient's response to aspiration. The scale ranges from score 1 (Material does not enter the airway) to score 8 (Material enters the airway, passes below the level of the vocal folds, and no effort is made to eject)
Time frame: Baseline, At 2, 4, and 8 weeks from baseline
The scale contains 14 categories that represent both oral functions (lip, closure, mastication , bolus formation, premature bolus loss, apraxia and oral transit time) and pharyngeal functions (pharyngeal triggering, laryngeal elevation, epiglottic closure, pharyngeal transit time, pharyngeal coating, vallecular and pyriform sinus residues, and tracheal aspiration), with a sum of 100 points.
Time frame: Baseline, At 2, 4, and 8 weeks from baseline
K-MASA assesses 24 skills related to sensory and oral motor elements of swallowing. Performance for each skill is measured using a 5- or 10-points rating scale and tallied to create a total numeric score out of 200 possible points, which are interpreted as no abnormality (≥178), mild dysphagia (168-177), moderate dysphagia (139-167) and severe (≤138)
Time frame: Baseline, At 4, and 8 weeks from baseline
The test consists of 13 questions to evaluate the structure of the articulatory system, including the face, lips, tongue, jaw, teeth, oral cavity, soft palate, pharynx, and breathing; 17 questions to evaluate the function of the articulatory system; 3 questions to auditorily evaluate the structure and function of the vocal system; and 14 questions to evaluate the regularity and articulation accuracy of the mutual movement of the articulatory system during articulatory alternation.
Time frame: Baseline, At 4, and 8 weeks from baseline
U-TAP is a test designed for native speakers of the Korean language. It is aimed to evaluate the pronunciation produced in words and sentences by patients with speech sound disorders who have problems with consonant or vowel sounds. It is recorded by phonological word and syllable position and calculates consonant accuracy and word-level phonological indices at the word and sentence levels to compare with normal articulation development
Time frame: Baseline, At 2, 4, and 8 weeks from baseline
mRS is composed of a 6-point assessment that includes reference to both limitations in activity and changes in lifestyle. The mRS possible scores vary from 0 (no symptoms) to 6 (dead) points
Time frame: Baseline, At 2, 4, and 8 weeks from baseline
The assessment is composed of two parts, the preliminary assessment (indirect swallowing test) and the direct swallowing test, which consist of 4 items with 3 subtests (semisolid, liquid and solid). The test is based on a pointing system where higher numbers denote better performance, with a maximum of 5 points that can be reached in each subtest.
Time frame: Baseline, At 2, 4, and 8 weeks from baseline
The EAT-10 is a tool to assess self-perceived symptoms of oropharyngeal dysphagia and monitor changes in response to a treatment. It consists of ten items to be rated on a 5-point response scale (0-4), with "0" = No problem and "4" = Severe problem, the maximum score possible is 40.
Time frame: Baseline, At 4, and 8 weeks from baseline
IOPI is a standardized portable device that is used to quantify tongue and lips isometric strength and endurance.
Time frame: Baseline, At 2 and 4 weeks from baseline
The cortical excitability of the area corresponding to the swallowing movement will be assessed by changes in the amplitude and latency of the MEPs by using transcranial magnetic stimulation (TMS).
Time frame: Baseline, At 4, and 8 weeks from baseline
GRBAS scale is used by researchers and clinicians for rating voice quality using a 4-point Likert scale with the following judgments: 0 = normal, 1 = mild impairment, 2 = moderate impairment, and 3 = severe impairment.
Time frame: Baseline, At 4, and 8 weeks from baseline
Respiratory muscle strength will be assessed by maximal inspiratory and expiratory pressure
Time frame: Baseline, At 4, and 8 weeks from baseline
Peak cough flow measures the maximum expiratory flow during the compressive phase of a cough just after sudden opening of the glottis
Contact information is provided by the study sponsor or research team.
NEUROPHET
Industry
A Multi-center, Randomized, Double-blind, Pilot Study to Evaluate the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Transitory Improvement of Swallowing Function in Patients With Post-stroke Dysphagia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07627399
Acute Stroke, Body Temperature Changes
Antequera, Málaga, Spain
View Trial DetailsNCT07267468
Brain Diseases, Cardiovascular Diseases
Algeciras, Cadiz, Spain
View Trial DetailsNCT05935618
Deglutition Disorders, Digestive System Diseases
Hvidovre, Denmark
View Trial DetailsNCT06219200
Deglutition Disorders, Digestive System Diseases
Lissone, Lombardy, Italy
View Trial Details